Annual Results Presentation 2020
Improving Global Animal Health and Welfare
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide.
For more information please visitwww.dechra.com
Companion Animal Products (CAP)
Species: Dogs and cats.
Key therapeutic sectors: Endocrinology, dermatology, analgesia and anaesthesia, antibiotics, cardiovascular and critical care.
Food producing Animal Products (FAP)
Species: Poultry, pigs and an increasing presence in cattle.
Key therapeutic sectors: Water soluble antibiotics, poultry vaccines, locomotion (lameness) and pain management.
Nutrition
Species: Dogs and cats.
Key therapeutic sectors: Our pet diets are available to support the wellbeing of cats and dogs with numerous therapeutic conditions, such as allergies, obesity, heart and kidney disease.
Operational Highlights
Delivering our strategy
Portfolio Focus
• CAP performance robust
• FAP growth accelerating
Pipeline Delivery
• Numerous product registrations achieved
• Significant progress made on Akston and Tri-Solfen
Geographic Expansion
• Increasing footprint through acquisition and licensing
• Dechra branded organisations delivering strong growth
Acquisition
• Ampharmco integration progressing well
• Mirataz acquisition completed in April 2020
• Osurnia acquisition completed in July 2020
Financial Highlights
Strong revenue and EBIT growth
Revenue Growth
• + 6.8% to £515.1 million
Operating Cash Generation
• 99.4% cash conversion
Underlying EBIT Growth
• Increase to £128.3 million
• EBIT margin (excluding impact of pension credit) reduction by 80 bps to 24.9% due to mix effect
Shareholders' Value
• Underlying diluted EPS +1.7% to 92.19 pence
• Full year dividend 34.29 pence
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Dechra Pharmaceuticals plc published this content on 07 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 September 2020 12:09:05 UTC